Stansberry Research

U.S. Late-Day Stock Moves: TPTX, CVGW, OKTA, JOAN, HCP

Daniel SmootStansberry NewsWire

Advances:

  • Turning Point Therapeutics (TPTX) +116.6%. TPTX will be acquired by Bristol-Myers Squibb (BMY) for $4.1 billion.
  • Calavo Growers (CVGW) +12.6%. CVGW's second-quarter earnings and revenue came in above estimates.
  • Okta (OKTA) +5.9%. OKTA's first-quarter revenue, billings, and operating income were stronger than anticipated.

Declines:

  • JOANN (JOAN) -20%. JOAN's first-quarter earnings, margins, and comparable-store sales disappointed.
  • HashiCorp (HCP) -18.5%. Analysts were focused on a slight deceleration in HCP's growth.